US2023272336A1PendingUtilityA1

Cell culture method using amino acid-enriched medium

Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Apr 26, 2007Filed: Apr 28, 2023Published: Aug 31, 2023
Est. expiryApr 26, 2027(~0.7 yrs left)· nominal 20-yr term from priority
C12N 5/0018C07K 16/2866C07K 16/303C12P 21/02C07K 2317/24C12N 2500/32C12N 2500/33C12N 2510/02C12N 5/00A61P 37/04C12N 15/11C12N 5/10C12P 21/00
78
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of culturing cells capable of producing desired proteins to obtain the proteins by use of a medium from which biological components are excluded as much as possible are provided. Specifically, a culture method characterized by culturing while maintaining a specific amino acid in a culture solution at a high concentration, and a cell culture fed-batch medium for use in the method are provided.

Claims

exact text as granted — not AI-modified
1 . A method of culturing a cell comprising culturing a cell capable of producing a desired protein in a culture solution in which a concentration of serine in the culture solution is maintained at 1 mM or higher at least during a certain period after onset of a cell growth phase, and obtaining the desired protein. 
     
     
         2 . The method of  claim 1 , wherein a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or at 0.4 mM or higher at least during the certain period after onset of the cell growth phase. 
     
     
         3 . A method of culturing a cell, comprising culturing a cell capable of producing a desired protein a culture solution in which a concentration of serine in the culture solution is maintained at 1 mM or higher at least during a part of or an entire period sufficient to enable the cell that is to be cultured to grow sufficiently, or during a part of or an entire period sufficient to enable adequate production of the desired protein that is to be produced. 
     
     
         4 . The method of  claim 3 , wherein a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or at 0.4 mM or higher at least during a part of or the entire period sufficient to enable the cell that is to be cultured to grow sufficiently, or during a part of or the entire period sufficient to enable adequate production of the desired protein that is to be produced. 
     
     
         5 . A method of culturing a cell, comprising culturing a cell capable of producing a desired protein in a culture solution in which a concentration of serine in the culture solution is maintained at 1 mM or higher at least during a part of or an entire period of an exponential cell growth phase, and obtaining the desired protein. 
     
     
         6 . The method of  claim 5 , wherein a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or higher or at 0.4 mM or higher at least during a part of or an entire period of the exponential cell growth phase. 
     
     
         7 . The method of  claim 4  wherein the concentration of serine in the culture solution is maintained at 2 mM or higher at least during a part of or an entire period of the exponential cell growth phase. 
     
     
         8 . A method of culturing a cell, comprising culturing a cell capable of producing a desired protein in a culture solution in which a concentration of serine in the culture solution is maintained at 1 mM or higher at least during a part of or an entire period from a third day to a tenth day of the culture, and obtaining the desired protein. 
     
     
         9 . The method of  claim 7 , wherein a concentration of tyrosine in the culture solution is maintained at 1 mM or higher, and/or a concentration of cysteine in the culture solution is maintained at a concentration of the cysteine in an initial medium or higher or at 0.4 mM or higher at least during a part of or an entire period from the third day to the tenth day of the culture. 
     
     
         10 . The method of  claim 8 , wherein the concentration of serine in the culture solution is maintained at 2 mM or higher at least during a part of or an entire period from the third day to the tenth day of the culture. 
     
     
         11 . The method of  claim 1 , wherein the cell is cultured by batch culture, repeated batch culture, fed-batch culture, repeated fed-batch culture, continuous culture, or perfusion culture. 
     
     
         12 . The method of  claim 1 , wherein the cell is cultured by fed-batch culture. 
     
     
         13 . The method of  claim 12 , wherein the serine and tyrosine and/or cysteine are fed into the culture solution in multiple batches sequentially or continuously. 
     
     
         14 . The method of  claim 1 , wherein the cell is transformed with a gene encoding the desired protein. 
     
     
         15 . The method of  claim 14 , wherein the desired protein is an antibody. 
     
     
         16 . The method of  claim 1 , wherein the cell is a mammal cell. 
     
     
         17 . The method of  claim 16 , wherein the mammal cell is a CHO cell. 
     
     
         18 . A fed-batch medium for culturing a cell, comprising serine at a concentration of 10 mM to 1000 mM. 
     
     
         19 . A fed-batch medium for culturing a cell, comprising serine at a concentration of 20 mM to 500 mM. 
     
     
         20 . The fed-batch medium of  claim 18 , further comprising cysteine and/or tyrosine. 
     
     
         21 . The fed-batch medium of  claim 18 , further comprising cysteine and tyrosine.

Join the waitlist — get patent alerts

Track US2023272336A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.